|
|
Article: Pharmacia & Upjohn Receives FDA 'Approvable' Letter for VESTRA(TM).
- Article from:
- PR Newswire
- Article date:
- July 30, 1999
CopyrightCOPYRIGHT 1999 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BRIDGEWATER, N.J., July 30 /PRNewswire/ -- Pharmacia & Upjohn (NYSE: PNU) is pleased to announce that the U.S. Food and Drug Administration (FDA) late yesterday issued an "approvable letter" for the company's antidepressant, VESTRA(TM) (reboxetine mesylate tablets). Pharmacia & Upjohn will continue to work with the FDA to secure final approval for VESTRA and anticipates a fourth quarter launch in the United States.
As previously announced, Pharmacia & Upjohn has entered into an agreement with Janssen Pharmaceutica to co-promote VESTRA in the United States. Under terms of the agreement, Janssen, a wholly owned subsidiary of Johnson & Johnson, will promote VESTRA ...